All companies
Visit website
JelikaLite
OperatingJelikaLite Corp.
Healthcare · Technology · Founded 2021
Precision autism through light
Post-money valuation ⓘ
$11.8M
As of Jan 2022 · from JelikaLite Common Stock 1 · pre-money + amount raised, not a traded price
Total raised
$616,996
Across 1 round since 2021
Latest share price
$0.65
JelikaLite Common Stock 1 offering price
Financials
FY2019–FY2021 · from SEC filings · hover any figure for its source$0
−$58K
2019
$0
−$166K
2020
$0
−$54K
2021
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019
FY2020
FY2021
Income statement
Revenue
$0
$0
$0
Cost of goods sold
$0
$0
$0
Net income
-$58,032
-$166,212
-$53,894
Taxes paid
$0
$0
$0
Balance sheet
Cash
$73,516
$104,845
$81,163
Accounts receivable
$0
$0
$0
Total assets
$73,516
$104,845
$91,163
Short-term debt
$2,848
$388
$388
Long-term debt
$100,000
$300,000
$470,000
Total liabilities
$102,848
$300,388
$470,388
Other
Headcount
—
4
4
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$11.8M
post-money
JelikaLite Common Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $617K / $1.1MInvestors 125Post-money $11.8M
Reg CF annual-report compliance
Not requiredFewer than 300 holders of record
Filed 1 of 5 annual reports (FY2021–FY2025)
125 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001894308Share price $0.65
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.